Garber AJ,Handelsman Y,Einhorn D,Bergman DA,Bloomgarden ZT,Fonseca V .2008 .Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocrine practice, 14(7) : 933-46.
Mavrogiannaki AN,Migdalis IN .2013 .Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. International Journal of Endocrinology, : 450639.
Paschos P,Paletas K. .2009 .Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia, 13(1) : 9-19.
Shyangdan D,Clar C,Ghouri N,Henderson R,Gurung T,Preiss D .2011 .Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15(38) : 1-110.
Ahmed M. .2015 .Non-alcoholic fatty liver disease in 2015. World journal of hepatology, 7(11) : 1450-9.
Kneeman JM,Misdraji J,Corey KE .2012 .Secondary causes of nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology, 5(3) : 199-207.
Pereira K,Salsamendi J,Casillas J .2015 .The global nonalcoholic fatty liver disease epidemic: what a radiologist needs to know. Journal of Clinical Imaging Science, 5 : 32.
Day CP,James OF .1998 .Steatohepatitis: a tale of two "hits". ? Gastroenterology, 114(4) : 842-5.
Gusdon AM,Song KX,Qu S. Nonalcoholic .2014 .Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. Oxidative Medicine and Cellular Longevity, : 637027.
Nassir F,Ibdah JA .2014 .Role of mitochondria in nonalcoholic fatty liver disease. International Journal of Molecular Sciences, 15(5) : 8713-42.
van der Poorten D,Milner KL,Hui J,Hodge A,Trenell MI,Kench JG .2008 .Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2) : 449-57.
Van Wagner LB,Rinella ME .2011 .The role of insulinsensitizing agents in the treatment of nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology, 4(4) : 249-63.
Ortiz-Lopez C,Lomonaco R,Orsak B,Finch J,Chang Z,Kochunov VG .2012 .Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care, 35(4) : 873-8.
Singh SP,Singh A,Pati GK,Misra B,Misra D,Kar SK .2014 .A study of prevalence of diabetes and prediabetes in patients of non-alcoholic fatty liver disease and the impact of diabetes on liver histology in coastal eastern India. Journal of Diabetes Mellitus, 4(4) : 290-6.
Zelber-Sagi S,Lotan R,Shibolet O,Webb M,Buch A,Nitzan-Kaluski D .2013 .Non-alcoholic fatty liver disease independently predicts prediabetes during a 7- year prospective follow-up. Liver International, 33(9) : 1406-12.
Mottin CC,Moretto M,Padoin AV,Swarowsky AM,Toneto MG,Glock L .2004 .The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obesity surgery, 14(5) : 635-7.
Barritt ASt,Dellon ES,Kozlowski T,Gerber DA,Hayashi PH .2011 .The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. Journal of Clinical Gastroenterology, 45(4) : 372-8.
Bahcecioglu IH,Koruk M,Yilmaz O,Bolukbas C,Bolukbas F,Tuncer I .2006 .Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. Medical Principles and Practice, 15(1) : 62-8.
Schwimmer JB MN,Deutsch R,Finegold MJ,Lavine JE .2005 .Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics, 115 : 561-5.
Karpe F,Dickmann JR,Frayn KN .2011 .Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes, 60(10) : 2441-9.
Lankarani KB,Ghaffarpasand F,Mahmoodi M,Lotfi M,Zamiri N,Heydari ST .2013 .Non alcoholic fatty liver disease in southern Iran: a population based study. Hepatitis monthly, 13(5) : e9248.